A (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.

Dogs that have oral squamous cell carcinomas often need surgery that disfigures their jaws and lower their quality of ...

Key Takeaways Incyte shares sank Monday after the drugmaker released the latest data from a clinical trial.The drug, ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Tv Therapeutics said that the U.S. FDA has lifted the clinical hold on the cadisegliatin clinical program, including late ...

Cadisegliatin, which was paused in the third phase of its CATT1 trial, is taken orally and is designed to target the liver specifically and aims to treat diabetes by improving blood sugar control. VTv ...

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetesCATT1 Phase 3 trial expected to resume following ...

Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side ...

The owners of a Pembroke Pines-based medical research facility pleaded guilty Monday to charges they faked information around ...

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...

Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer ...

Multiracial growth impacts clinical trials. Explore challenges in race classification, health disparities, and genomic profiling.